KEGG   Puma yagouaroundi (jaguarundi): 121025049
Entry
121025049         CDS       T07555                                 
Symbol
IKBKG
Name
(RefSeq) NF-kappa-B essential modulator isoform X1
  KO
K07210  inhibitor of nuclear factor kappa-B kinase subunit gamma
Organism
pyu  Puma yagouaroundi (jaguarundi)
Pathway
pyu01523  Antifolate resistance
pyu04010  MAPK signaling pathway
pyu04014  Ras signaling pathway
pyu04062  Chemokine signaling pathway
pyu04064  NF-kappa B signaling pathway
pyu04151  PI3K-Akt signaling pathway
pyu04210  Apoptosis
pyu04380  Osteoclast differentiation
pyu04620  Toll-like receptor signaling pathway
pyu04621  NOD-like receptor signaling pathway
pyu04622  RIG-I-like receptor signaling pathway
pyu04623  Cytosolic DNA-sensing pathway
pyu04625  C-type lectin receptor signaling pathway
pyu04657  IL-17 signaling pathway
pyu04658  Th1 and Th2 cell differentiation
pyu04659  Th17 cell differentiation
pyu04660  T cell receptor signaling pathway
pyu04662  B cell receptor signaling pathway
pyu04668  TNF signaling pathway
pyu04920  Adipocytokine signaling pathway
pyu04936  Alcoholic liver disease
pyu05010  Alzheimer disease
pyu05132  Salmonella infection
pyu05135  Yersinia infection
pyu05142  Chagas disease
pyu05145  Toxoplasmosis
pyu05160  Hepatitis C
pyu05161  Hepatitis B
pyu05162  Measles
pyu05163  Human cytomegalovirus infection
pyu05164  Influenza A
pyu05165  Human papillomavirus infection
pyu05166  Human T-cell leukemia virus 1 infection
pyu05167  Kaposi sarcoma-associated herpesvirus infection
pyu05168  Herpes simplex virus 1 infection
pyu05169  Epstein-Barr virus infection
pyu05170  Human immunodeficiency virus 1 infection
pyu05171  Coronavirus disease - COVID-19
pyu05200  Pathways in cancer
pyu05203  Viral carcinogenesis
pyu05208  Chemical carcinogenesis - reactive oxygen species
pyu05212  Pancreatic cancer
pyu05215  Prostate cancer
pyu05220  Chronic myeloid leukemia
pyu05221  Acute myeloid leukemia
pyu05222  Small cell lung cancer
pyu05235  PD-L1 expression and PD-1 checkpoint pathway in cancer
pyu05340  Primary immunodeficiency
pyu05417  Lipid and atherosclerosis
pyu05418  Fluid shear stress and atherosclerosis
Brite
KEGG Orthology (KO) [BR:pyu00001]
 09130 Environmental Information Processing
  09132 Signal transduction
   04010 MAPK signaling pathway
    121025049 (IKBKG)
   04014 Ras signaling pathway
    121025049 (IKBKG)
   04064 NF-kappa B signaling pathway
    121025049 (IKBKG)
   04668 TNF signaling pathway
    121025049 (IKBKG)
   04151 PI3K-Akt signaling pathway
    121025049 (IKBKG)
 09140 Cellular Processes
  09143 Cell growth and death
   04210 Apoptosis
    121025049 (IKBKG)
 09150 Organismal Systems
  09151 Immune system
   04620 Toll-like receptor signaling pathway
    121025049 (IKBKG)
   04621 NOD-like receptor signaling pathway
    121025049 (IKBKG)
   04622 RIG-I-like receptor signaling pathway
    121025049 (IKBKG)
   04623 Cytosolic DNA-sensing pathway
    121025049 (IKBKG)
   04625 C-type lectin receptor signaling pathway
    121025049 (IKBKG)
   04660 T cell receptor signaling pathway
    121025049 (IKBKG)
   04658 Th1 and Th2 cell differentiation
    121025049 (IKBKG)
   04659 Th17 cell differentiation
    121025049 (IKBKG)
   04657 IL-17 signaling pathway
    121025049 (IKBKG)
   04662 B cell receptor signaling pathway
    121025049 (IKBKG)
   04062 Chemokine signaling pathway
    121025049 (IKBKG)
  09152 Endocrine system
   04920 Adipocytokine signaling pathway
    121025049 (IKBKG)
  09158 Development and regeneration
   04380 Osteoclast differentiation
    121025049 (IKBKG)
 09160 Human Diseases
  09161 Cancer: overview
   05200 Pathways in cancer
    121025049 (IKBKG)
   05208 Chemical carcinogenesis - reactive oxygen species
    121025049 (IKBKG)
   05203 Viral carcinogenesis
    121025049 (IKBKG)
   05235 PD-L1 expression and PD-1 checkpoint pathway in cancer
    121025049 (IKBKG)
  09162 Cancer: specific types
   05212 Pancreatic cancer
    121025049 (IKBKG)
   05221 Acute myeloid leukemia
    121025049 (IKBKG)
   05220 Chronic myeloid leukemia
    121025049 (IKBKG)
   05215 Prostate cancer
    121025049 (IKBKG)
   05222 Small cell lung cancer
    121025049 (IKBKG)
  09172 Infectious disease: viral
   05166 Human T-cell leukemia virus 1 infection
    121025049 (IKBKG)
   05170 Human immunodeficiency virus 1 infection
    121025049 (IKBKG)
   05161 Hepatitis B
    121025049 (IKBKG)
   05160 Hepatitis C
    121025049 (IKBKG)
   05171 Coronavirus disease - COVID-19
    121025049 (IKBKG)
   05164 Influenza A
    121025049 (IKBKG)
   05162 Measles
    121025049 (IKBKG)
   05168 Herpes simplex virus 1 infection
    121025049 (IKBKG)
   05163 Human cytomegalovirus infection
    121025049 (IKBKG)
   05167 Kaposi sarcoma-associated herpesvirus infection
    121025049 (IKBKG)
   05169 Epstein-Barr virus infection
    121025049 (IKBKG)
   05165 Human papillomavirus infection
    121025049 (IKBKG)
  09171 Infectious disease: bacterial
   05132 Salmonella infection
    121025049 (IKBKG)
   05135 Yersinia infection
    121025049 (IKBKG)
  09174 Infectious disease: parasitic
   05145 Toxoplasmosis
    121025049 (IKBKG)
   05142 Chagas disease
    121025049 (IKBKG)
  09163 Immune disease
   05340 Primary immunodeficiency
    121025049 (IKBKG)
  09164 Neurodegenerative disease
   05010 Alzheimer disease
    121025049 (IKBKG)
  09166 Cardiovascular disease
   05417 Lipid and atherosclerosis
    121025049 (IKBKG)
   05418 Fluid shear stress and atherosclerosis
    121025049 (IKBKG)
  09167 Endocrine and metabolic disease
   04936 Alcoholic liver disease
    121025049 (IKBKG)
  09176 Drug resistance: antineoplastic
   01523 Antifolate resistance
    121025049 (IKBKG)
 09180 Brite Hierarchies
  09181 Protein families: metabolism
   01001 Protein kinases [BR:pyu01001]
    121025049 (IKBKG)
Protein kinases [BR:pyu01001]
 Serine/threonine kinases: Other
  IKK family [OT]
   121025049 (IKBKG)
SSDB
Motif
Pfam: CC2-LZ NEMO zf_C2H2_10 Zn_SUZ12 LLC1 Nairovirus_NSm ABC_membrane_2
Other DBs
NCBI-GeneID: 121025049
NCBI-ProteinID: XP_040323334
LinkDB
Position
Unknown
AA seq 419 aa
MSRPPWKSQLCEMVQPSGGPAGDQDVLGEESSLGKPAMPHLPSEQGTPETFQRCVEENQE
LRDAIRQSNQMLRERCEELQRFQGSQRKEKEFLMQKFQEARKLVERLSLEKLDLRRQREQ
ALQEVEHLKRCQKQLAEDKASVKAQVTSLLGELQESQSRLEAAIKERQALEGRARAASEQ
ARQLESEREALQQQHSVQVDQLRMQSQSVEAALRMERQAASEEKRKLAQLQVAYHQLFQE
YDSHIKSSVVSSERNRGLQLEDLKQQLQQAEEALVAKQEVIDKLKEEAEQHKIVMETVPV
LKAQADIYKADFQAERQAREKLAEKKEILQEQLAQLQRDYSRLKASCQESARIEDMRKRH
VEASQAPVAPAPAHPSFHLALPNQRRSPPEEPPDFCCPKCQYQAPDMDTLQIHVMECIE
NT seq 1260 nt   +upstreamnt  +downstreamnt
atgagcaggcccccctggaagagtcagctgtgtgagatggtgcagcccagcggcggcccg
gcaggggaccaggacgtgctgggtgaagagtcttctctggggaagccagctatgccccac
ctaccttctgagcagggcactcctgagaccttccaacgctgtgtggaggagaatcaagag
ctccgagatgccatccggcagagcaaccagatgcttcgggagcgctgtgaggagctgcag
cgtttccaaggcagccagaggaaagagaaggagttcctcatgcagaaatttcaggaagcc
aggaaactggtggagagactgagcctggagaagctcgacctgaggagacagagggagcag
gccctgcaggaggtggaacatctgaagagatgccagaagcagttggctgaggacaaggcg
tcagtgaaagcccaggtgacgtccttgctgggggagctccaagagagccagagtcgcttg
gaggccgccatcaaagagcgacaggctttggagggcagggcccgggctgccagcgagcag
gcccggcagctggagagtgagcgggaggccctgcagcagcagcacagtgtgcaggtggac
cagctgcgcatgcagagccagagcgtggaggccgcgctgcgcatggagcgccaggccgcc
tcggaggagaagcggaagctggcgcagctacaggtggcctatcaccagctcttccaggag
tacgacagccacatcaagagcagcgtggtgagcagcgagcggaaccgaggactgcagctg
gaggacctgaagcagcagctgcaacaggccgaggaggccctggtggccaagcaggaagtg
attgacaagctgaaggaagaggccgagcagcacaagatagtgatggagaccgttccggtg
ctaaaagcccaggcggacatctacaaggccgacttccaggccgagaggcaggcccgggag
aagctggcagagaagaaggagattctgcaggagcagctggcccagctgcagcgggactac
agccgcctgaaggccagctgccaggagtccgccaggattgaagatatgaggaagcggcac
gtggaggcctcccaggcccccgtagcccctgccccagctcacccctccttccacctggcc
ctgcccaaccagaggagaagcccccccgaggagccgcctgacttctgttgccccaagtgc
cagtatcaggctcccgatatggacaccctgcagatacatgtcatggagtgcatcgagtag

DBGET integrated database retrieval system